Pacira Biosciences, Inc. · NASDAQ:PCRX
Cross Shawn sold 12,059 Pacira Biosciences, Inc. shares (Form 4)
Traded Apr 20 to Apr 22, 2026 · Filed Apr 22, 2026
From Apr 20 to Apr 22, 2026, Cross Shawn (Chief Financial Officer) sold 12,059 Pacira Biosciences, Inc. shares at an average US$25.09 for US$303K under a trading plan, leaving 105,341 shares. Filed Apr 22, 2026 (Form 4).
- Sold
- 12,059 shares
- Price
- US$25.09 average (US$25.01 to US$25.14)
- Value
- US$303K
- Holding after
- 105,341 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 20, 2026 | Common Stock | Option exercise | 7,714 | US$16.45 | 113,055 | Direct |
| Apr 20, 2026 | Common Stock | Sale | 7,714 | US$25.14 | 105,341 | Direct |
| Apr 21, 2026 | Common Stock | Option exercise | 2,845 | US$16.45 | 108,186 | Direct |
| Apr 21, 2026 | Common Stock | Sale | 2,845 | US$25.01 | 105,341 | Direct |
| Apr 22, 2026 | Common Stock | Option exercise | 1,500 | US$16.45 | 106,841 | Direct |
| Apr 22, 2026 | Common Stock | Sale | 1,500 | US$25.01 | 105,341 | Direct |
Source
Related
- Pacira Biosciences, Inc.
- Cross Shawn
- Pacira Biosciences, Inc. shareholders
- Form 4 · Cross Shawn · Apr 24, 2026
- Schedule 13D/A · Doma Perpetual Capital Management LLC · Oct 13, 2026
- Form 4 · Riker Lauren · Oct 9, 2026
- Form 4 · Slonin Jonathan · Aug 18, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Riker Lauren · Jun 12, 2026